Artículos por temáticas

Is Parkinson's disease a neurodevelopmental disorder and will brain organoids help us to understand it?

Schwamborn JC.

Stem Cells Dev. 2018 Feb 7. doi: 10.1089/scd.2017.0289. [Epub ahead of print]

Baseline concentration of misfolded α-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson's disease.

Ning H, Wu Q, Han D, Yao T, Wang J, Lu W, Lv S, Jia Q, Li X.

Neuropathol Appl Neurobiol. 2018 Oct 22. doi: 10.1111/nan.12524. [Epub ahead of print]

Biomarkers for cognitive dysfunction in Parkinson's disease.

Kalia LV.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S19-S23. doi: 10.1016/j.parkreldis.2017.07.023. Epub 2017 Jul 24.

The effects of exercise on cognition and gait in Parkinson's disease: A scoping review.

Intzandt B, Beck EN, Silveira CRA.

Neurosci Biobehav Rev. 2018 Oct 3;95:136-169. doi: 10.1016/j.neubiorev.2018.09.018. [Epub ahead of print] Review.

Parkinson's disease: symptoms, treatment options and nursing care.

Cotterell P.

Nurs Stand. 2018 Sep 10. doi: 10.7748/ns.2018.e11207. [Epub ahead of print]

Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.

Panchal SC, Ondo WG.

Curr Psychiatry Rep. 2018 Jan 27;20(1):3. doi: 10.1007/s11920-018-0869-z. Review.

Cannabinoids Somewhat Helpful for Nausea, Maybe Helpful for Spasticity, Probably Not Helpful for Nonneuropathic Pain.

Ebell MH.

Am Fam Physician. 2018 Oct 15;98(8):Online. No abstract available.

Comparison of Tractography-Assisted to Atlas-Based Targeting for Deep Brain Stimulation in Essential Tremor.

Fenoy AJ, Schiess MC.

Mov Disord. 2018 Sep 5. doi: 10.1002/mds.27463. [Epub ahead of print]

Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease.

Tinaz S, Chow C, Kuo PH, Krupinski EA, Blumenfeld H, Louis ED, Zubal G.

Clin Nucl Med. 2018 Jan;43(1):e1-e7. doi: 10.1097/RLU.0000000000001885.

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4).

Chahine LM, Beach TG, Seedorff N, Caspell-Garcia C, Coffey CS, Brumm M, Adler CH, Serrano GE, Linder C, Mosovsky S, Foroud T, Riss H, Ecklund D, Seibyl J, Jennings D, Arnedo V, Riley L, Dave K, Mollen

J Parkinsons Dis. 2018 Sep 21. doi: 10.3233/JPD-181434. [Epub ahead of print]

Positive clinical effects of gamma knife capsulotomy in a patient with deep brain stimulation-refractory Tourette Syndrome and Obsessive Compulsive Disorder.

Richieri R, Blackman G, Musil R, Spatola G, Cavanna AE, Lançon C, Régis J.

Clin Neurol Neurosurg. 2018 Jul;170:34-37. doi: 10.1016/j.clineuro.2018.04.018. Epub 2018 Apr 26.

Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.

Goh AM, Wibawa P, Loi SM, Walterfang M, Velakoulis D, Looi JC.

Australas Psychiatry. 2018 Aug;26(4):366-375. doi: 10.1177/1039856218791036. Epub 2018 Jul 16.

Network imaging biomarkers: insights and clinical applications in Parkinson's disease.

Schindlbeck KA, Eidelberg D.

Lancet Neurol. 2018 Jul;17(7):629-640. doi: 10.1016/S1474-4422(18)30169-8. Review.

Pharmacological treatment for REM sleep behavior disorder in Parkinson disease and related conditions: A scoping review.

de Almeida CMO, Pachito DV, Sobreira-Neto MA, Tumas V, Eckeli AL.

J Neurol Sci. 2018 Aug 10;393:63-68. doi: 10.1016/j.jns.2018.08.008. [Epub ahead of print] Review.

Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease.

Vilas D, Gelpi E, Aldecoa I, Grau O, Rodriguez-Diehl R, Jaumà S, Martí MJ, Tolosa E.

J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318473. doi: 10.1136/jnnp-2018-318473. [Epub ahead of print] No abstract available.